The American public deserves leaders who are cognitively capable of performing the demands of office. Neither Republicans nor ...

Tuesday, Sage Therapeutics, Inc. (NASDAQ:SAGE) released topline results from the Phase 2 LIGHTWAVE study to evaluate the ...

If you’re having memory problems and are above 60, get tested for free to check if your cognitive health is really impaired.

Outcomes may improve with disease-modifying drugs and lifestyle change if Alzheimer's could be identified earlier.

Sage Therapeutics shares fell as much as 25% in premarket trading after the company announced disappointing topline results from its Phase 2 LIGHTWAVE study of dalzanemdor (SAGE-718) for the treatment ...

Sage Therapeutics has seen another clinical trial go up in smoke. | Sage Therapeutics has seen another clinical trial go up ...

Qr8 Health announced the appointment of Kelly Keegan as Chief Commercial Officer (CCO). Keegan brings more than 30 years of experience as a dynamic and entrepreneurial leader in the healthcare ...

A new intervention improves sleep and reduces the burden on healthcare providers who treat patients with insomnia.

Was there a gradual decline? Or did it happen all of a sudden? This too you should discuss with your doctor, who might recommend the MoCA, or Montreal Cognitive Assessment test, which screens for ...

Sage has decided to discontinue the development of dalzanemdor in Alzheimer’s disease. A study of the candidate in Huntington ...

The outpatient service of "spatial and mathematics learning difficulty" at the Shanghai Children's Medical Center officially ...

Zety®, a career service dedicated to helping people improve their resumes and cover letters, today announced the findings from its HR and AI Recruitment Report, which polled 500 HR managers about ...